{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:02:05Z","timestamp":1780473725469,"version":"3.54.1"},"reference-count":14,"publisher":"Galenos Yayinevi","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2026.04710","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:33:59Z","timestamp":1771500839000},"page":"194-197","source":"Crossref","is-referenced-by-count":0,"title":["Curing the \u201cIncurable\u201d: First Successful Hematopoietic Stem Cell Transplantation in Severe Hereditary Spherocytosis with Homozygous SPTA1 Variant and Hepatic Fibrosis"],"prefix":"10.4274","volume":"43","author":[{"given":"Deniz","family":"Ko\u00e7ak G\u00f6l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veysel","family":"G\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekrem","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Karak\u00fckc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Do\u011fru \u00d6, Alavanda C, Demir \u015e, Ko\u00e7 A, Ata P. Multigene panel testing reveals novel variants in hereditary spherocytosis patients in T\u00fcrkiye. Turk J Hematol. 2025;42:25-32.","DOI":"10.4274\/tjh.galenos.2025.2024.0270"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Ramanathan S, Roberts W, Carey P, Marshall S, Shenton G, Munoz-Diaz M, Biss T, Skinner R, Fuente J, Slatter M, Lum SH. Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutation. Pediatr Blood Cancer. 2023;70:e29928.","DOI":"10.1002\/pbc.29928"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Do\u011fru \u00d6, Alavanda C, Demir \u015e, Ko\u00e7 A, Ata P. Multigene panel testing reveals novel variants in hereditary spherocytosis patients in T\u00fcrkiye. Turk J Hematol. 2025;42:25-32.","DOI":"10.4274\/tjh.galenos.2025.2024.0270"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Blanc L, Wolfe LC. General conditions of hemolytic disease, red cell membrane and enzyme defects. In: Lanzkowsky P (ed). Manual of Pediatric Hematology and Oncology. 7th ed. San Diego, Elsevier Academic Press, 2022.","DOI":"10.1016\/B978-0-12-821671-2.00030-1"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Wu Y, Liao L, Lin F. The diagnostic protocol for hereditary spherocytosis-2021 update. J Clin Lab Anal. 2021;35:e24034.","DOI":"10.1002\/jcla.24034"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/ejh.14194","article-title":"Identification of the molecular etiology in rare congenital hemolytic anemias using next-generation sequencing with exome-based copy number variant analysis","volume":"113","author":"Isik","year":"2024","unstructured":"6. Isik E, Aydinok Y, Albayrak C, Durmus B, Karakas Z, Orhan MF, Sarper N, Ayd\u0131n S, Unal S, Oymak Y, Karadas N, Turedi A, Albayrak D, Tayfun F, Tugcu D, Karaman S, Tobu M, Unal E, Ozcan A, Unal S, Aksu T, Unuvar A, Bilici M, Azik F, Ay Y, Gelen SA, Zengin E, Albudak E, Eker I, Karakaya T, Cogulu O, Ozkinay F, Atik T. Identification of the molecular etiology in rare congenital hemolytic anemias using next-generation sequencing with exome-based copy number variant analysis. Eur J Haematol. 2024;113:82-89.","journal-title":"Eur J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Narla J, Mohandas N. Red cell membrane disorders. Int J Lab Hematol. 2017;39(Suppl 1):47-52.","DOI":"10.1111\/ijlh.12657"},{"key":"ref7","unstructured":"8. Zamora EA, Schaefer CA. Hereditary spherocytosis. In: StatPearls [Internet]. Treasure Island, StatPearls Publishing, 2023."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1515\/cclm-2016-0738","article-title":"Advances in laboratory diagnosis of hereditary spherocytosis","volume":"55","author":"Farias","year":"2017","unstructured":"9. Farias MG. Advances in laboratory diagnosis of hereditary spherocytosis. Clin Chem Lab Med. 2017;55:944-948.","journal-title":"Clin Chem Lab Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000486229","article-title":"Molecular genetic mechanisms of hereditary spherocytosis: current perspectives","volume":"139","author":"BJ","year":"2018","unstructured":"10. He BJ, Liao L, Deng ZF, Tao YF, Xu YC, Lin FQ. Molecular genetic mechanisms of hereditary spherocytosis: current perspectives. Acta Haematol. 2018;139:60-66.","journal-title":"Acta Haematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0301-472X(00)00491-4","article-title":"Amelioration of severe hereditary spherocytosis in nonablated adult mice by marrow transplantation","volume":"28","author":"Barker","year":"2000","unstructured":"11. Barker JE, Deveau S, Wandersee NJ. Amelioration of severe hereditary spherocytosis in nonablated adult mice by marrow transplantation. Exp Hematol. 2000;28:985-992.","journal-title":"Exp Hematol"},{"key":"ref11","unstructured":"12. Comit\u00e9 Nacional de Hematolog\u00eda; Donato H, Crisp RL, Rapetti MC, Garc\u00eda E, Attie M. Hereditary spherocytosis. Review. Part II. Symptomatology, outcome, complications, and treatment. Arch Argent Pediatr. 2015;113:168-176."},{"key":"ref12","unstructured":"13. Zhang XH, Fu HX, Xu LP, Liu DH, Chen H, Han W, Chen YH, Wang FR, Wang JZ, Wang Y, Zhao T, Liu KY, Huang XJ. Allo-hematopoietic stem cell transplantation is a potential treatment for a patient with a combined disorder of hereditary spherocytosis. Chin Med J (Engl). 2012;125:947-950."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Ramanathan S, Roberts W, Carey P, Marshall S, Shenton G, Munoz-Diaz M, Biss T, Skinner R, Fuente J, Slatter M, Lum SH. Allogenic haematopoeitic stem cell transplant as cure for severe transfusion-dependent non-dominant hereditary spherocytosis due to homozygous SPTA1 mutation. Pediatr Blood Cancer. 2023;70:e29928.","DOI":"10.1002\/pbc.29928"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:12:16Z","timestamp":1780470736000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z5\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-04710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2026.04710","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}